SCHEMBL266474

SCHEMBL266474

Cc1[nH]cnc1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3448931 0.98 KDM4E (0.51)
SCHEMBL11395633 0.98 KDM4E (0.51)
Lithium SCHEMBL29505670 0.98 KDM4E (0.51)
SCHEMBL2100653 0.82
SCHEMBL2588734 0.80
Potassium Ion SCHEMBL11400680 0.78 GABRR1 (0.44)
Hydrochloric Acid SCHEMBL11004255 0.78 GABRR1 (0.44)
SCHEMBL11395637 0.78 GABRR1 (0.44)
SCHEMBL7104572 0.77 GAA (0.54)
SCHEMBL1498468 0.77 BCAT2 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4063023-A Process for preparing 4-(hydroxymethyl)imidazole compounds SK&F LAB CO. (US) 1977-12-13 US claimed
US-20240175141-A1 BIOBASED AND BIODEGRADABLE CORROSION INHIBITION COMPOSITION ZestBio, Inc. 2024-05-30 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-3969439-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2022-03-23 EP disclosed
WO-2020251957-A1 PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF TEON THERAPEUTICS, INC. (US) 2020-12-17 WO disclosed
US-10377739-B2 Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” (RU) 2019-08-13 US disclosed
CN-109715609-A Cyclohexylbenzoyl amine compounds 伊莱利利公司 2019-05-03 CN disclosed
US-20190084961-A1 Glutarimide Derivatives, Use Thereof, Pharmaceutical Composition Based Thereon and Methods for Producing Glutarimide Derivatives OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU "PHARMENTERPRISES" (RU) 2019-03-21 US disclosed
US-10196377-B2 Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” (RU) 2019-02-05 US disclosed
US-20180022728-A1 Glutarimide Derivatives, Use Thereof, Pharmaceutical Composition Based Thereon and Methods for Producing Glutarimide Derivatives OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU "PHARMENTERPRISES" (RU) 2018-01-25 US disclosed
US-4743586-A PREPARATION FROM A METHYLAMINE, 2-OXIME OF ETHYL 2,3-DIOXOBUTYRATE, HYDRAZINE, TRIETHOXYMETHANE AMERICAN CYANAMID COMPANY (US) 1988-05-10 US disclosed
EP-0049638-B1 PROCESS FOR PREPARARING 5-METHYL-4-IMIDAZOLECARBOXYLIC ACID ESTERS SMITHKLINE BECKMAN CORPORATION (US) 1987-04-01 EP disclosed
EP-0189458-A1 IMIDAZOLE PLANT GROWTH REGULATORS FMC Corporation (US) 1986-08-06 EP disclosed
US-4565875-A Imidazole plant growth regulators FMC CORPORATION (US) 1986-01-21 US disclosed
WO-1986000305-A1 IMIDAZOLE PLANT GROWTH REGULATORS FMC CORPORATION (US) 1986-01-16 WO disclosed
US-4539331-A ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC LABORATORIOS VITA, S.A. (ES) 1985-09-03 US disclosed
US-4374252-A Benzyl 5-methyl-4-imidazolecarboxylate SK&F LAB CO. (US) 1983-02-15 US disclosed
US-4328349-A Process for preparing 5-methyl-4-imidazolecarboxylic acid esters SK&F LAB CO. (US) 1982-05-04 US disclosed
EP-0049638-A1 Process for prepararing 5-methyl-4-imidazolecarboxylic acid esters SMITHKLINE BECKMAN CORPORATION (US) 1982-04-14 EP disclosed
US-4055573-A TO 4-HYDROXYMETHYL OR ALKOXYMETHYL IMIDAZOLES SMITHKLINE CORPORATION (US) 1977-10-25 US disclosed